Literature DB >> 21275946

Evaluation of platelet transfusion clinical trials.

Laurence Corash, Claire D Sherman.   

Abstract

Mesh：

Year:  2011        PMID： 21275946     DOI： 10.1111/j.1365-2141.2010.08413.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  Pathogen inactivation technologies for cellular blood components: an update.

Authors:  Peter Schlenke
Journal:  Transfus Med Hemother       Date:  2014-07-21       Impact factor: 3.747

2.  LC-MS/MS analysis and comparison of oxidative damages on peptides induced by pathogen reduction technologies for platelets.

Authors:  Michel Prudent; Giona Sonego; Mélanie Abonnenc; Jean-Daniel Tissot; Niels Lion
Journal:  J Am Soc Mass Spectrom       Date:  2014-01-28       Impact factor: 3.109

Review 3.  Improving platelet transfusion safety: biomedical and technical considerations.

Authors:  Olivier Garraud; Fabrice Cognasse; Jean-Daniel Tissot; Patricia Chavarin; Syria Laperche; Pascal Morel; Jean-Jacques Lefrère; Bruno Pozzetto; Miguel Lozano; Neil Blumberg; Jean-Claude Osselaer
Journal:  Blood Transfus       Date:  2015-11-16       Impact factor: 3.443

Review 4.  Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion.

Authors:  Giona Sonego; Mélanie Abonnenc; Jean-Daniel Tissot; Michel Prudent; Niels Lion
Journal:  Int J Mol Sci       Date:  2017-02-11       Impact factor: 5.923

Review 5.  [Photochemical inactivation of pathogens in platelets and plasma: five years of clinical use in routine and hemovigilance. Towards a change of paradigm in transfusion safety].

Authors:  J-P Cazenave
Journal:  Transfus Clin Biol       Date:  2011-04-06       Impact factor: 1.406
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.